{"resourceType":"Condition","id":"49056","meta":{"versionId":"1","lastUpdated":"2022-12-21T10:03:16.059+01:00","source":"#ZmyYfeh8AYhjUAYS","profile":["http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Condition-primaryCancer-eu-pcsp"]},"language":"ES","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/condition-assertedDate","valueDateTime":"2012-04-17"},{"url":"http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-histology-morphology-behavior","valueCodeableConcept":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/icd-o-3","code":"9896/3","display":"Leucemia mieloide aguda, LMA1(CBF- alfa)/ETO  ( maligno ) "}]}}],"bodySite":[{"extension":[{"url":"http://hl7.eu/fhir/ig/pcsp/StructureDefinition/mcode-laterality-qualifier","valueCodeableConcept":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/data-absent-reason","code":"not-applicable","display":"No aplicable"}]}}],"coding":[{"system":"http://terminology.hl7.org/CodeSystem/icd-o-3","code":"C42","display":"Médula ósea  [C42 SISTEMAS HEMATOPOYÉTICO Y RETICULOENDOTELIAL ] "}]}],"subject":{"reference":"Patient/49055","type":"Patient"},"evidence":[{"code":[{"coding":[{"system":"http://snomed.info/sct","code":"365861007","display":"Evidencia de estado Inmune"}],"text":"CD43, lisozima, mieloperoxidasa, CD34 positivo; Vimentina CD20, Cd3 negativo"}]},{"code":[{"coding":[{"system":"http://snomed.info/sct","code":"106221001","display":"Evidencia de Marcadores Genéticos"}],"text":"t(8;21), pérdida de cromosoma Y, AML1/ETO +; RUNX1/RUNX1T1 positivo, FLT3 mutación D835, mutación CKIT exón 8 - , exón 17 +"}]}]}
